Unrelated stem cell transplantation for patients with multiple myeloma.

Standard

Unrelated stem cell transplantation for patients with multiple myeloma. / Kröger, Nicolaus.

in: CURR OPIN HEMATOL, Jahrgang 17, Nr. 6, 6, 2010, S. 538-543.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{6b488da61fc540afbf9386b0aef85c0c,
title = "Unrelated stem cell transplantation for patients with multiple myeloma.",
abstract = "The role of allogeneic stem cell transplantation (SCT) in treatment of myeloma patients is still controversial. Meanwhile, the numbers of unrelated SCT for hematological diseases in Europe are higher than for human leukocyte antigen (HLA)-identical sibling transplantations, but in multiple myeloma only 39% of the allogeneic transplantations are performed from unrelated donors and only a minority were done within prospective clinical trials.",
author = "Nicolaus Kr{\"o}ger",
year = "2010",
language = "Deutsch",
volume = "17",
pages = "538--543",
journal = "CURR OPIN HEMATOL",
issn = "1065-6251",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

RIS

TY - JOUR

T1 - Unrelated stem cell transplantation for patients with multiple myeloma.

AU - Kröger, Nicolaus

PY - 2010

Y1 - 2010

N2 - The role of allogeneic stem cell transplantation (SCT) in treatment of myeloma patients is still controversial. Meanwhile, the numbers of unrelated SCT for hematological diseases in Europe are higher than for human leukocyte antigen (HLA)-identical sibling transplantations, but in multiple myeloma only 39% of the allogeneic transplantations are performed from unrelated donors and only a minority were done within prospective clinical trials.

AB - The role of allogeneic stem cell transplantation (SCT) in treatment of myeloma patients is still controversial. Meanwhile, the numbers of unrelated SCT for hematological diseases in Europe are higher than for human leukocyte antigen (HLA)-identical sibling transplantations, but in multiple myeloma only 39% of the allogeneic transplantations are performed from unrelated donors and only a minority were done within prospective clinical trials.

M3 - SCORING: Zeitschriftenaufsatz

VL - 17

SP - 538

EP - 543

JO - CURR OPIN HEMATOL

JF - CURR OPIN HEMATOL

SN - 1065-6251

IS - 6

M1 - 6

ER -